'Monoclonal antibody therapy' diaporamas de présentation

Overview of Current and Emerging Small Molecules and Monoclonal Antibodies in MS

Overview of Current and Emerging Small Molecules and Monoclonal Antibodies in MS . Clyde E. Markowitz, MD Director, Multiple Sclerosis Center University of Pennsylvania Philadelphia, Pennsylvania. Introduction. Traditional 1st-line MS therapies reduce relapse rates and slow progression

868 views • 58 slides

Monoclonal Antibodies in Cancer Treatment

Monoclonal Antibodies in Cancer Treatment. Monoclonal Antibody Therapy for Cancer. FDA approved:. Rituximab anti-CD20 lymphoma Herceptin anti-her2/neu breast cancer Myelotarg anti-CD33 AML Campath anti-CD52 CLL Zevalin 90 Y anti-CD20 lymphoma Bexxar 131 I anti-CD20 lymphoma.

2.15k views • 41 slides

Customized Cancer Medicine

Customized Cancer Medicine. All Treatments are Customized at the point of delivery All Treatments Are Designed to Take advantage of Differences between Cancer Cells and Normal Cells

463 views • 34 slides

Treatment options depend on the following: The stage of the cancer

258 views • 12 slides

A Cancer Biomarker Screen for Drug Target Selection

198 views • 7 slides